The Disability Integration Toolkit was developed at SUNY Upstate to help educators enhance medical students’ knowledge, skills, and cultural competencies regarding the care of people with disability. Read the full Perspective: nej.md/3VfdklB

Original Article: Stress Ulcer Prophylaxis during Invasive Mechanical Ventilation (REVISE) nej.md/3KD01Xp

Editorial: Uncertain Answers — Proton-Pump Inhibition in the ICU nej.md/4cdGAAm

#CCR24 | Critical Care Reviews

Original Article: Liberal or Restrictive Transfusion Strategy in Patients with Traumatic Brain Injury (HEMOTION) nej.md/3VaQhZa

#CCR24 | Critical Care Reviews

To learn more about this NEJM Illustrated Glossary term, read “JAK Inhibition Immunotherapy for APS-1” by Maureen A. Su, M.D.: nej.md/4cfs5Mv 

Explore more terms: nej.md/glossary

JAK–STAT signaling: A pathway through which cytokines and growth factors affect transcriptional changes important in the development of autoimmunity. nej.md/3xbjhIt

In a trial from China involving 1412 patients with acute ischemic stroke presenting within 4.5 hours, the percentage who had an excellent functional outcome at 90 days was 79.5% with reteplase and 70.4% with alteplase. Full RAISE trial results: nej.md/3VlxL0e

Just published: 'Proton-Pump Inhibitors to Prevent Gastrointestinal Bleeding — An Updated Meta-Analysis” by Ying Wang, MSc, Deborah Cook, MD, MSc, et al. eviden.cc/4aONMBD

Yaseen Arabi Paul Young #CCR24

Jessica Lewis discusses a group prenatal care program aimed at improving maternal and infant health in diverse patient populations. Listen to the full interview: nej.md/4bUWIa7

A 59-year-old veterinarian presented with a 1-year history of a painful rash on his hand. Verrucous plaques with overlying thick yellow-brown crusting were seen on the dorsum of the hand and the medial aspect of a finger. Full clinical case: nej.md/3yZHpOY

Influenza A(H5N1) virus has been identified in dairy herds and in the commercial milk supply. In a new report, inactivation of the virus in milk by heating is studied. Read the full report: nej.md/3KK7ELM

Among 15 patients with relapsed ALCL after the failure of brentuximab vedotin therapy, the ALK inhibitor brigatinib led to a complete response in 73%, and progression-free survival at 2 years was 73%. Read the full correspondence: nej.md/4efG1rw

Medical students and faculty at the University of Pittsburgh have been teaching middle-school students from marginalized racial and ethnic groups how to perform bystander CPR. Read the full Perspective: nej.md/4ecKhb9

Original Article: Noninvasive Ventilation for Preoxygenation during Emergency Intubation (PREOXI) nej.md/45lC0xt

#CCR24 | Critical Care Reviews